KEGG   PATHWAY: puc05169
Entry
puc05169                    Pathway                                
Name
Epstein-Barr virus infection - Panthera uncia (snow leopard)
Description
Epstein-Barr virus (EBV) is a gamma-herpes virus that widely infects human populations predominantly at an early age but remains mostly asymptomatic. EBV has been linked to a wide spectrum of human malignancies, including nasopharyngeal carcinoma and other hematologic cancers, like Hodgkin's lymphoma, Burkitt's lymphoma (BL), B-cell immunoblastic lymphoma in HIV patients, and posttransplant-associated lymphoproliferative diseases.  EBV has the unique ability to establish life-long latent infection in primary human B lymphocytes. During latent infection, EBV expresses a small subset of genes, including 6 nuclear antigens (EBNA-1, -2, -3A, -3B, -3C, and -LP), 3 latent membrane proteins (LMP-1, -2A, and -2B), 2 small noncoding RNAs (EBER-1 and 2). On the basis of these latent gene expression, three different latency patterns associated with the types of cancers are recognized.
Class
Human Diseases; Infectious disease: viral
Pathway map
puc05169  Epstein-Barr virus infection
puc05169

Organism
Panthera uncia (snow leopard) [GN:puc]
Gene
125925339  complement receptor type 2 isoform X1 [KO:K04012]
125928006  B-lymphocyte antigen CD19 isoform X1 [KO:K06465]
125938154  HLA class II histocompatibility antigen, DR alpha chain-like [KO:K06752]
125938382  HLA class II histocompatibility antigen, DP beta 1 chain-like [KO:K06752]
125938383  HLA class II histocompatibility antigen, DP alpha 1 chain [KO:K06752]
125938384  LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DO alpha chain [KO:K06752]
125938386  HLA class II histocompatibility antigen, DM alpha chain isoform X1 [KO:K06752]
125938388  HLA class II histocompatibility antigen, DM beta chain [KO:K06752]
125938395  HLA class II histocompatibility antigen, DO beta chain-like isoform X1 [KO:K06752]
125938398  DLA class II histocompatibility antigen, DR-1 beta chain isoform X1 [KO:K06752]
125938399  DLA class II histocompatibility antigen, DR-1 beta chain-like isoform X1 [KO:K06752]
125938400  HLA class II histocompatibility antigen, DR alpha chain [KO:K06752]
125923764  toll-like receptor 2 [KO:K10159]
125921434  myeloid differentiation primary response protein MyD88 [KO:K04729]
125918985  interleukin-1 receptor-associated kinase 4 [KO:K04733] [EC:2.7.11.1]
125932080  interleukin-1 receptor-associated kinase 1 [KO:K04730] [EC:2.7.11.1]
125934537  TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
125919627  TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 [KO:K04403]
125938017  TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404]
125938695  mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
125932873  inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
125923306  inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
125932096  NF-kappa-B essential modulator isoform X1 [KO:K07210]
125909567  NF-kappa-B inhibitor alpha [KO:K04734]
125923687  nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
125912163  transcription factor p65 [KO:K04735]
125938466  tumor necrosis factor [KO:K03156]
125930836  interleukin-6 [KO:K05405]
125918656  antiviral innate immune response receptor RIG-I isoform X1 [KO:K12646] [EC:5.6.2.6]
125936139  mitochondrial antiviral-signaling protein isoform X1 [KO:K12648]
125909139  TNF receptor-associated factor 3 isoform X1 [KO:K03174]
125919296  serine/threonine-protein kinase TBK1 [KO:K05410] [EC:2.7.11.10]
125925487  inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X1 [KO:K07211] [EC:2.7.11.10]
125937759  interferon regulatory factor 7 isoform X1 [KO:K09447]
125915966  interferon regulatory factor 3 isoform X1 [KO:K05411]
125925935  interferon beta-like [KO:K05414]
125925953  interferon alpha-2-like [KO:K05414]
125925944  interferon beta [KO:K05415]
125921711  interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
125921705  interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
125913423  tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
125930538  non-receptor tyrosine-protein kinase TYK2 isoform X1 [KO:K11219] [EC:2.7.10.2]
125911435  signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
125920249  signal transducer and activator of transcription 2 [KO:K11221]
125909651  interferon regulatory factor 9 [KO:K04693]
125937286  interferon-induced, double-stranded RNA-activated protein kinase isoform X1 [KO:K16195] [EC:2.7.11.1]
125914169  2'-5'-oligoadenylate synthase 3 [KO:K14216] [EC:2.7.7.84]
125914170  2'-5'-oligoadenylate synthase 2 [KO:K14216] [EC:2.7.7.84]
125914171  2'-5'-oligoadenylate synthase 1 [KO:K14216] [EC:2.7.7.84]
125922838  C-X-C motif chemokine 10 [KO:K12671]
125913254  ubiquitin-like protein ISG15 [KO:K12159]
125933220  tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
125929964  FAS-associated death domain protein [KO:K02373]
125911772  caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
125918699  BH3-interacting domain death agonist [KO:K04726]
125937460  bcl-2-like protein 11 isoform X1 [KO:K16341]
125914709  apoptosis regulator Bcl-2 [KO:K02161]
125915138  apoptosis regulator BAX isoform X1 [KO:K02159]
125938359  bcl-2 homologous antagonist/killer [KO:K14021]
125929995  cytochrome c [KO:K08738]
125933126  LOW QUALITY PROTEIN: cytochrome c-like [KO:K08738]
125920151  cytochrome c-like [KO:K08738]
125920269  cytochrome c-like [KO:K08738]
125921158  cytochrome c-like [KO:K08738]
125919454  apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
125913078  caspase-9 [KO:K04399] [EC:3.4.22.62]
125923904  caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
125909427  T-cell surface glycoprotein CD3 epsilon chain [KO:K06451]
125909383  T-cell surface glycoprotein CD3 gamma chain [KO:K06452]
125909406  T-cell surface glycoprotein CD3 delta chain [KO:K06450]
125925894  T-cell surface glycoprotein CD3 zeta chain isoform X1 [KO:K06453]
125929844  26S proteasome regulatory subunit 7 [KO:K03061]
125909259  26S proteasome regulatory subunit 4 [KO:K03062]
125915899  26S proteasome regulatory subunit 6B [KO:K03063]
125908768  26S proteasome regulatory subunit 10B [KO:K03064]
125934056  26S proteasome regulatory subunit 6A [KO:K03065]
125926676  26S proteasome regulatory subunit 8 isoform X1 [KO:K03066]
125921121  26S proteasome non-ATPase regulatory subunit 2 [KO:K03028]
125931749  LOW QUALITY PROTEIN: 26S proteasome non-ATPase regulatory subunit 1-like [KO:K03032]
125911095  26S proteasome non-ATPase regulatory subunit 1 [KO:K03032]
125926490  26S proteasome non-ATPase regulatory subunit 3 isoform X1 [KO:K03033]
125926687  26S proteasome non-ATPase regulatory subunit 12 [KO:K03035]
125927487  26S proteasome non-ATPase regulatory subunit 11 [KO:K03036]
125929542  26S proteasome non-ATPase regulatory subunit 6 [KO:K03037]
125916298  26S proteasome non-ATPase regulatory subunit 7 [KO:K03038]
125937741  26S proteasome non-ATPase regulatory subunit 13 isoform X1 [KO:K03039]
125912102  26S proteasome non-ATPase regulatory subunit 4 isoform X1 [KO:K03029]
125911593  26S proteasome non-ATPase regulatory subunit 14 isoform X1 [KO:K03030]
125915784  26S proteasome non-ATPase regulatory subunit 8 [KO:K03031]
125936430  proteasomal ubiquitin receptor ADRM1 [KO:K06691]
125939091  26S proteasome complex subunit SEM1-like [KO:K10881]
125938390  antigen peptide transporter 1 [KO:K05653] [EC:7.4.2.14]
125938391  antigen peptide transporter 2 [KO:K05654] [EC:7.4.2.14]
125938368  LOW QUALITY PROTEIN: tapasin [KO:K08058]
125909939  protein disulfide-isomerase A3 [KO:K08056] [EC:5.3.4.1]
125929051  calreticulin [KO:K08057]
125938453  DLA class I histocompatibility antigen, A9/A9 alpha chain-like isoform X1 [KO:K06751]
125938456  class I histocompatibility antigen, Gogo-B*0101 alpha chain-like isoform X1 [KO:K06751]
125938457  class I histocompatibility antigen, Gogo-B*0101 alpha chain-like [KO:K06751]
125938459  patr class I histocompatibility antigen, A-2 alpha chain-like isoform X1 [KO:K06751]
125938460  LOW QUALITY PROTEIN: class I histocompatibility antigen, Gogo-C*0201 alpha chain-like [KO:K06751]
125938463  DLA class I histocompatibility antigen, A9/A9 alpha chain-like isoform X1 [KO:K06751]
125938464  DLA class I histocompatibility antigen, A9/A9 alpha chain-like [KO:K06751]
125909955  beta-2-microglobulin [KO:K08055]
125909304  SNW domain-containing protein 1 [KO:K06063]
125910154  paired amphipathic helix protein Sin3a [KO:K11644]
125938817  histone deacetylase 2 isoform X1 [KO:K06067] [EC:3.5.1.98]
125932228  LOW QUALITY PROTEIN: histone deacetylase 1-like [KO:K06067] [EC:3.5.1.98]
125912823  histone deacetylase 1 isoform X1 [KO:K06067] [EC:3.5.1.98]
125914361  nuclear receptor corepressor 2 [KO:K06065]
125923214  histone deacetylase complex subunit SAP30 isoform X1 [KO:K19202]
125934516  histone deacetylase complex subunit SAP30L [KO:K19202]
125911828  corepressor interacting with RBPJ 1 [KO:K06066]
125923549  recombining binding protein suppressor of hairless isoform X1 [KO:K06053]
125936553  recombining binding protein suppressor of hairless-like protein [KO:K06053]
125921073  transcription factor HES-1 [KO:K06054]
125928973  low affinity immunoglobulin epsilon Fc receptor isoform X1 [KO:K06468]
125912943  runt-related transcription factor 3 [KO:K09279]
125924410  myc proto-oncogene protein [KO:K04377]
125927866  ubiquitin carboxyl-terminal hydrolase 7 isoform X1 [KO:K11838] [EC:3.4.19.12]
125919324  E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
125927023  LOW QUALITY PROTEIN: cellular tumor antigen p53 [KO:K04451]
125938307  cyclin-dependent kinase inhibitor 1 [KO:K06625]
125929753  growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
125930526  growth arrest and DNA damage-inducible protein GADD45 beta isoform X1 [KO:K04402]
125912521  growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
125933993  DNA damage-binding protein 2 isoform X1 [KO:K10140]
125935748  DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
125925301  TNF receptor-associated factor 5 isoform X1 [KO:K09849]
125921850  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
125913143  LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
125921289  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
125913493  phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
125935698  phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
125929237  phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649]
125915806  RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
125909102  RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
125925091  RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
125926656  mitogen-activated protein kinase kinase kinase 14 isoform X1 [KO:K04466] [EC:2.7.11.25]
125915169  transcription factor RelB [KO:K09253]
125932909  nuclear factor NF-kappa-B p100 subunit [KO:K04469]
125916585  tumor necrosis factor receptor type 1-associated DEATH domain protein [KO:K03171]
125915462  NF-kappa-B inhibitor beta isoform X1 [KO:K02581]
125911398  LOW QUALITY PROTEIN: NF-kappa-B inhibitor beta-like [KO:K02581]
125937893  NF-kappa-B inhibitor epsilon [KO:K05872]
125927589  dual specificity mitogen-activated protein kinase kinase 4 isoform X1 [KO:K04430] [EC:2.7.12.2]
125928966  dual specificity mitogen-activated protein kinase kinase 7 isoform X1 [KO:K04431] [EC:2.7.12.2]
125916877  mitogen-activated protein kinase 10-like [KO:K04440] [EC:2.7.11.24]
125917114  mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
125933328  mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
125935352  mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
125923516  TNF receptor-associated factor 2 isoform X1 [KO:K03173] [EC:2.3.2.27]
125939602  receptor-interacting serine/threonine-protein kinase 1 [KO:K02861] [EC:2.7.11.1]
125926929  dual specificity mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
125926707  dual specificity mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
125937867  mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
125937868  mitogen-activated protein kinase 14 isoform X1 [KO:K04441] [EC:2.7.11.24]
125919741  mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
125919935  mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
125912547  transcription factor Jun [KO:K04448]
125923918  ectonucleoside triphosphate diphosphohydrolase 8 [KO:K01510] [EC:3.6.1.5]
125932830  ectonucleoside triphosphate diphosphohydrolase 1 isoform X1 [KO:K01510] [EC:3.6.1.5]
125921406  ectonucleoside triphosphate diphosphohydrolase 3 [KO:K01510] [EC:3.6.1.5]
125936517  tumor necrosis factor receptor superfamily member 5 isoform X1 [KO:K03160]
125934691  CD44 antigen isoform X1 [KO:K06256]
125928080  integrin alpha-L isoform X1 [KO:K05718]
125913288  lymphocyte function-associated antigen 3 isoform X1 [KO:K06492]
125930551  intercellular adhesion molecule 1 isoform X1 [KO:K06490]
125919995  vimentin isoform X1 [KO:K07606]
125938952  tumor necrosis factor alpha-induced protein 3 [KO:K11859] [EC:3.4.19.12]
125929213  tyrosine-protein kinase JAK3 isoform X1 [KO:K11218] [EC:2.7.10.2]
125926571  signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
125924861  tyrosine-protein kinase Lyn isoform X1 [KO:K05854] [EC:2.7.10.2]
125924291  tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
125917249  E3 ubiquitin-protein ligase NEDD4 isoform X1 [KO:K10591] [EC:2.3.2.26]
125917260  E3 ubiquitin-protein ligase NEDD4 isoform X1 [KO:K10591] [EC:2.3.2.26]
125928294  ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
125931830  tyrosine-protein kinase BTK isoform X1 [KO:K07370] [EC:2.7.10.2]
125933413  B-cell linker protein isoform X1 [KO:K07371]
125916347  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
125934645  S-phase kinase-associated protein 2 [KO:K03875]
125918841  cyclin-dependent kinase inhibitor 1B [KO:K06624]
125930010  G1/S-specific cyclin-D1 [KO:K04503]
125917183  G1/S-specific cyclin-D2 [KO:K10151]
125918030  G1/S-specific cyclin-D2 [KO:K10151]
125938244  G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
125919257  cyclin-dependent kinase 4 isoform X1 [KO:K02089] [EC:2.7.11.22]
125930419  cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
125918223  cyclin-A2 [KO:K06627]
125918226  cyclin-A2 [KO:K06627]
125933710  cyclin-A1 [KO:K06627]
125924535  G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
125917277  G1/S-specific cyclin-E1 [KO:K06626]
125917289  G1/S-specific cyclin-E1 [KO:K06626]
125919210  cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
125933773  retinoblastoma-associated protein isoform X1 [KO:K06618]
125936106  transcription factor E2F1 [KO:K17454]
125912975  transcription factor E2F2 [KO:K09389]
125908499  transcription factor E2F3 [KO:K06620]
Compound
C00076  Calcium cation
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Young LS, Rickinson AB.
  Title
Epstein-Barr virus: 40 years on.
  Journal
Nat Rev Cancer 4:757-68 (2004)
DOI:10.1038/nrc1452
Reference
  Authors
Saha A, Robertson ES
  Title
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
  Journal
Clin Cancer Res 17:3056-63 (2011)
DOI:10.1158/1078-0432.CCR-10-2578
Reference
  Authors
Ning S
  Title
Innate immune modulation in EBV infection.
  Journal
Herpesviridae 2:1 (2011)
DOI:10.1186/2042-4280-2-1
Reference
  Authors
Stanfield BA, Luftig MA
  Title
Recent advances in understanding Epstein-Barr virus.
  Journal
F1000Res 6:386 (2017)
DOI:10.12688/f1000research.10591.1
Reference
  Authors
van Gent M, Braem SG, de Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME
  Title
Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.
  Journal
PLoS Pathog 10:e1003960 (2014)
DOI:10.1371/journal.ppat.1003960
Reference
  Authors
Rajsbaum R, Garcia-Sastre A
  Title
Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways.
  Journal
Trends Microbiol 21:421-9 (2013)
DOI:10.1016/j.tim.2013.06.006
Reference
  Authors
Hoffmann HH, Schneider WM, Rice CM
  Title
Interferons and viruses: an evolutionary arms race of molecular interactions.
  Journal
Trends Immunol 36:124-38 (2015)
DOI:10.1016/j.it.2015.01.004
Reference
  Authors
Spender LC, Inman GJ
  Title
Inhibition of germinal centre apoptotic programmes by epstein-barr virus.
  Journal
Adv Hematol 2011:829525 (2011)
DOI:10.1155/2011/829525
Reference
  Authors
Fu Q, He C, Mao ZR
  Title
Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.
  Journal
J Zhejiang Univ Sci B 14:8-24 (2013)
DOI:10.1631/jzus.B1200189
Reference
  Authors
Wang Y, Banerjee S, Ding L, Cai C, Wei F, Cai Q
  Title
The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers.
  Journal
Virol Sin 32:357-368 (2017)
DOI:10.1007/s12250-017-4081-9
Reference
  Authors
Melchjorsen J
  Title
Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.
  Journal
Viruses 5:470-527 (2013)
DOI:10.3390/v5020470
Reference
  Authors
Hansen TH, Bouvier M
  Title
MHC class I antigen presentation: learning from viral evasion strategies.
  Journal
Nat Rev Immunol 9:503-13 (2009)
DOI:10.1038/nri2575
Reference
  Authors
Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ
  Title
Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
  Journal
Semin Cancer Biol 18:397-408 (2008)
DOI:10.1016/j.semcancer.2008.10.008
Reference
  Authors
Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ
  Title
Viral evasion of T cell immunity: ancient mechanisms offering new applications.
  Journal
Curr Opin Immunol 23:96-103 (2011)
DOI:10.1016/j.coi.2010.11.005
Reference
  Authors
Ghosh Roy S, Robertson ES, Saha A
  Title
Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis.
  Journal
Biomolecules 6:E46 (2016)
DOI:10.3390/biom6040046
Reference
  Authors
Dawson CW, Port RJ, Young LS
  Title
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).
  Journal
Semin Cancer Biol 22:144-53 (2012)
DOI:10.1016/j.semcancer.2012.01.004
Reference
  Authors
Cai Q, Chen K, Young KH
  Title
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
  Journal
Exp Mol Med 47:e133 (2015)
DOI:10.1038/emm.2014.105
Reference
  Authors
Zheng H, Li LL, Hu DS, Deng XY, Cao Y
  Title
Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
  Journal
Cell Mol Immunol 4:185-96 (2007)
Reference
  Authors
Ersing I, Bernhardt K, Gewurz BE
  Title
NF-kappaB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.
  Journal
Viruses 5:1587-606 (2013)
DOI:10.3390/v5061587
Reference
  Authors
Wang LW, Jiang S, Gewurz BE
  Title
Epstein-Barr Virus LMP1-Mediated Oncogenicity.
  Journal
J Virol 91:e01718-16 (2017)
DOI:10.1128/JVI.01718-16
Reference
  Authors
Mori N, Morishita M, Tsukazaki T, Yamamoto N
  Title
Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
  Journal
Int J Cancer 105:661-8 (2003)
DOI:10.1002/ijc.11146
Reference
  Authors
Edwards RH, Marquitz AR, Raab-Traub N
  Title
Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
  Journal
MBio 6:e00441-15 (2015)
DOI:10.1128/mBio.00441-15
Reference
  Authors
Thorley-Lawson DA
  Title
Epstein-Barr virus: exploiting the immune system.
  Journal
Nat Rev Immunol 1:75-82 (2001)
DOI:10.1038/35095584
Reference
  Authors
Eliopoulos AG, Young LS
  Title
LMP1 structure and signal transduction.
  Journal
Semin Cancer Biol 11:435-44 (2001)
DOI:10.1006/scbi.2001.0410
Reference
  Authors
Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L
  Title
Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.
  Journal
J Biol Chem 278:47753-61 (2003)
DOI:10.1074/jbc.M307200200
Reference
  Authors
Kang H, Kiess A, Chung CH
  Title
Emerging biomarkers in head and neck cancer in the era of genomics.
  Journal
Nat Rev Clin Oncol 12:11-26 (2015)
DOI:10.1038/nrclinonc.2014.192
Reference
  Authors
Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM
  Title
Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.
  Journal
Cancers (Basel) 10:E213 (2018)
DOI:10.3390/cancers10070213
Reference
  Authors
Sato Y, Kamura T, Shirata N, Murata T, Kudoh A, Iwahori S, Nakayama S, Isomura H, Nishiyama Y, Tsurumi T
  Title
Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.
  Journal
PLoS Pathog 5:e1000530 (2009)
DOI:10.1371/journal.ppat.1000530
Reference
  Authors
Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES
  Title
Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
  Journal
J Virol 83:4652-69 (2009)
DOI:10.1128/JVI.02408-08
Reference
  Authors
Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES
  Title
Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.
  Journal
Virology 388:236-47 (2009)
DOI:10.1016/j.virol.2009.03.027
Reference
  Authors
Kumar P, Murakami M, Kaul R, Saha A, Cai Q, Robertson ES
  Title
Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.
  Journal
Future Virol 4:79-91 (2009)
DOI:10.2217/17460794.4.1.79
Reference
  Authors
Longnecker R
  Title
Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
  Journal
Adv Cancer Res 79:175-200 (2000)
DOI:10.1016/s0065-230x(00)79006-3
Reference
  Authors
El-Sharkawy A, Al Zaidan L, Malki A
  Title
Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis.
  Journal
Front Oncol 8:265 (2018)
DOI:10.3389/fonc.2018.00265
Reference
  Authors
Dolcetti R, Masucci MG
  Title
Epstein-Barr virus: induction and control of cell transformation.
  Journal
J Cell Physiol 196:207-18 (2003)
DOI:10.1002/jcp.10263
Reference
  Authors
Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES
  Title
Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
  Journal
PLoS Pathog 7:e1001275 (2011)
DOI:10.1371/journal.ppat.1001275
Related
pathway
puc03050  Proteasome
puc04010  MAPK signaling pathway
puc04020  Calcium signaling pathway
puc04064  NF-kappa B signaling pathway
puc04110  Cell cycle
puc04115  p53 signaling pathway
puc04210  Apoptosis
puc04612  Antigen processing and presentation
puc04620  Toll-like receptor signaling pathway
puc04622  RIG-I-like receptor signaling pathway
puc04630  JAK-STAT signaling pathway
puc04662  B cell receptor signaling pathway
KO pathway
ko05169   
LinkDB

DBGET integrated database retrieval system